Page last updated: 2024-11-11

gabalid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID6438152
CHEMBL ID1513232
CHEBI ID177635
SCHEMBL ID15296974
MeSH IDM0111379

Synonyms (24)

Synonym
84393-31-7
4-[[(9z,12z)-octadeca-9,12-dienoyl]amino]butanoic acid
n-linoleoyl-4-aminobutyric acid
CHEBI:177635
brn 4197167
gaba-linoleamide [french]
gabalid
(z,z)-4-((1-oxo-9,12-octadecadienyl)amino)butanoic acid
n-linoleoyl gaba [french]
gaba linoleamide
butanoic acid, 4-((1-oxo-9,12-octadecadienyl)amino)-, (z,z)-
gaba-linoleamide
NCGC00161220-02
n-linoleoyl gaba
z3nmx9471t ,
unii-z3nmx9471t
SCHEMBL15296974
CHEMBL1513232
butanoic acid, 4-(((9z,12z)-1-oxo-9,12-octadecadien-1-yl)amino)-
4-((9z,12z)-octadeca-9,12-dienamido)butanoic acid
Q27294952
DTXSID801182685
4-[[(9z,12z)-1-oxo-9,12-octadecadien-1-yl]amino]butanoic acid
PD062782

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
organonitrogen compoundAny heteroorganic entity containing at least one carbon-nitrogen bond.
organooxygen compoundAn organochalcogen compound containing at least one carbon-oxygen bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
phosphopantetheinyl transferaseBacillus subtilisPotency100.00000.141337.9142100.0000AID1490
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (93.75)18.7374
1990's1 (6.25)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.27 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]